Literature DB >> 15247359

Progress toward identifying aggressive prostate cancer.

Mario Eisenberger, Alan Partin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15247359     DOI： 10.1056/NEJMe048119

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.

Authors:  M Suzanne Stratton; Amit M Algotar; James Ranger-Moore; Steven P Stratton; Elizabeth H Slate; Chiu-Hsieh Hsu; Patricia A Thompson; Larry C Clark; Frederick R Ahmann
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-20

Review 2.  Continuing controversy over monitoring men with localized prostate cancer: a systematic review of programs in the prostate specific antigen era.

Authors:  Richard M Martin; David Gunnell; Freddie Hamdy; David Neal; Athene Lane; Jenny Donovan
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

3.  Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.

Authors:  Sabina Hussain; David Gunnell; Jenny Donovan; Sean McPhail; Freddie Hamdy; David Neal; Peter Albertsen; Julia Verne; Peter Stephens; Caroline Trotter; Richard M Martin
Journal:  BJU Int       Date:  2008-01-10       Impact factor: 5.588
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.